# Trial of Cytisine in Adult Smokers

> **NCT03709823** · PHASE2 · COMPLETED · sponsor: **Achieve Life Sciences** · enrollment: 254 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Cytisine
- **DRUG:** Placebo Comparator
- **BEHAVIORAL:** Behavioral support

## Key facts

- **NCT ID:** NCT03709823
- **Lead sponsor:** Achieve Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-13
- **Primary completion:** 2019-04-23
- **Final completion:** 2019-04-23
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709823, "Trial of Cytisine in Adult Smokers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03709823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*